Reports of Patent, Design, and Trade Mark Cases, Issues 13-25Published at the Patent Office Sales Branch, 2007 - Industrial property |
From inside the book
Results 1-3 of 26
Page 743
... citalopram At p.2 , 11.36-41 , the specification explains that the invention is also concerned with a method to resolve the racemate of citalopram into the individual isomers . It states that citalopram has been disclosed in , for ...
... citalopram At p.2 , 11.36-41 , the specification explains that the invention is also concerned with a method to resolve the racemate of citalopram into the individual isomers . It states that citalopram has been disclosed in , for ...
Page 786
... citalopram , escitalopram elicited an increase in brain serotonin levels that was about twice that with citalopram . Further , when escitalopram was administered together with twice or four times as much ( - ) citalopram , the ...
... citalopram , escitalopram elicited an increase in brain serotonin levels that was about twice that with citalopram . Further , when escitalopram was administered together with twice or four times as much ( - ) citalopram , the ...
Page 787
... citalopram was 3.5 points compared to citalopram over placebo of 1.3 points . 224 225 226 227 228 229 230 231 These studies were not specifically designed to test the efficacy of escitalopram over citalopram . Professor Montgomery ...
... citalopram was 3.5 points compared to citalopram over placebo of 1.3 points . 224 225 226 227 228 229 230 231 These studies were not specifically designed to test the efficacy of escitalopram over citalopram . Professor Montgomery ...
Contents
EDITORS INTRODUCTION | v |
CASES REPORTED IN NUMERICAL ORDER | xiv |
CASES NOTED IN JUDGMENTS AND DECISIONS REPORTED | xxiv |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
added subject matter agreement Akzo Nobel Angiotech Pharmaceuticals Inc Appeal to Court application for revocation Appointed Person BACTIGUARD chiral citalopram claimants co-proprietor's application common general knowledge comparative advertising Comptroller consent Court of Appeal decision declarations of invalidity DESIGN AND TRADE divisional applications Dr Pinkava duties earlier mark earlier trade mark enantiomers European patents evidence grounds for refusal Halliburton Energy Services hearing officer Intellectual Property Office inventive step issue jurisdiction L'Oréal licence LIFFE likelihood of confusion Lundbeck Malynicz non-use opposition parallel trading particulars of infringement patentable subject matter Patents Act 1977 Patents Court perfumes pharmaceutical Playtech prior art racemate referred registered proprietor registered trade mark registrar relation relative grounds relevant REPORTS OF PATENT restenosis skilled person smell-alike specification stent Sweet & Maxwell taxol tibolone TRADE MARK 2007 Trade Mark Application trade marks declarations United Kingdom validating amendments VITALITE Vitasoy